|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008972,
umls-concept:C0019139,
umls-concept:C0019169,
umls-concept:C0023981,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0524909,
umls-concept:C0699788,
umls-concept:C1512704,
umls-concept:C1623038,
umls-concept:C2587213
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-7-16
|
|
pubmed:abstractText |
To evaluate the effect of indigenous and imported low molecular weight heparin (LMWH) in the treatment of chronic hepatitis and hepatic cirrhosis aiming at seeking a safe and effective anti-fibrosis therapy.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1003-0603
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
408-11
|
|
pubmed:meshHeading |
pubmed-meshheading:17631708-Adult,
pubmed-meshheading:17631708-Aged,
pubmed-meshheading:17631708-Female,
pubmed-meshheading:17631708-Fibrinolytic Agents,
pubmed-meshheading:17631708-Heparin, Low-Molecular-Weight,
pubmed-meshheading:17631708-Hepatitis B, Chronic,
pubmed-meshheading:17631708-Humans,
pubmed-meshheading:17631708-Liver Cirrhosis,
pubmed-meshheading:17631708-Male,
pubmed-meshheading:17631708-Middle Aged,
pubmed-meshheading:17631708-Prospective Studies,
pubmed-meshheading:17631708-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
[Indigenous and imported low molecular weight heparin in the treatment of chronic hepatitis B and cirrhosis with hepatitis B virus: a prospective randomized controlled clinical study].
|
|
pubmed:affiliation |
Institute of Liver Disease, Hangzhou Sixth People's Hospital, Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310014, Zhejiang, China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
